Investigator initiated trial seeks to validate safety, efficacy of the NanoKnife System in treating targeted tumors while reducing or delaying need for radical intervention Approximately 40% of all ...
A woman who has received a breakthrough gene-editing treatment on the NHS is hoping 2026 is the year she will be cured of a ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback